Medication Intelligence Startup Arine Raises $29M

Sep 9, 2022 1 min read
Medication Intelligence Startup Arine Raises $29M

Originally published by HIT Consultant on August 18, 2022

What You Should Know:

Arine, a San Francisco-based next-generation medication intelligence company raises $29M in a Series B round funding composed of equity and debt financing led by 111° West Capital, with participation from new investors MBX Capital and New Leaf Ventures, and continued support from Katalyst Ventures.

– Founded in 2017, Arine helps health plans substantially decrease the cost of care and improve patient outcomes by reducing medication errors, avoiding complications, and keeping patients out of the hospital.

– Arine plans to use the latest funding to advance the capabilities of its platform to enable value-based care at scale, not only for health plans and risk-bearing providers, but also to expand its offerings to other channel partners across the value-based care continuum that can leverage Arine’s medication intelligence to achieve next-level outcomes.

Great! Next, complete checkout for full access to Agetech News.
Welcome back! You've successfully signed in.
You've successfully subscribed to Agetech News.
Success! Your account is fully activated, you now have access to all content.
Success! Your billing info has been updated.
Your billing was not updated.